Pharma Journalist -

Agenus announced the launch of a subsidiary company for its cell therapy business, AgenTus Therapeutics, Inc. The subsidiary is focused on realizing significant value for both…
Read More...

Eli Lilly and Company announced plans to invest $72 million in an insulin manufacturing project at one of its Indianapolis facilities. The investment will be used to replace an existing…
Read More...

TiGenix NV, an advanced biopharmaceutical company focused on exploiting the anti-inflammatory properties of allogeneic, or donor-derived, stem cells to develop novel therapies for…
Read More...

Titan Pharmaceuticals, Inc. announced the planned presentation of non-clinical data on the use of its ProNeura™ subdermal implant for the long-term, sustained delivery of liothyronine…
Read More...

Astellas Pharma Inc. and Universal Cells, Inc. announced that Astellas Institute for Regenerative Medicine ("AIRM") and Universal Cells have entered into an exclusive worldwide license…
Read More...

Agenus Inc., an immuno-oncology company with a pipeline of immune checkpoint antibodies and cancer vaccines, announced that the US Food and Drug Administration (FDA) granted marketing…
Read More...

Teva Pharmaceutical announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for fremanezumab, an anti-calcitonin gene-related…
Read More...

SMi Group are proud to present the 9th Annual RNA Therapeutics conference, taking place on 21st - 22nd February 2018 at Holiday Inn Kensington Forum, London,…
Read More...

Have you seen the complete agenda for the 10th annual Social Media in the Pharmaceutical Industry? Bringing in voices from top pharma companies and social media experts, to educate,…
Read More...

Amgen and Boston Children's Hospital announced that they have entered into a neuroscience research collaboration aimed at identifying novel pain targets based on human genetic analyses.…
Read More...